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SUMMARY 
Baseline plasma Cortisol levels and response to dexamethasone in a group of twenty five patienti with 
ma)or depressive disorder (Ml)D) and a control group of twenty five patients with psychiatric diagnoses other than 
MDD were estimated. The results of our study show that dexamethasone suppression test (DST) i« a useful 
diagnostic aid in MDD with melancholia with a sensitivity of 46% and specificity of 96%. Nonsuppression to DST is 
a marker of the state of melancholia and is not influenced by any other demographic or clinical variable. In our study 
4 p.m. sample alone identified all the DST positive patients. MDD with melancholia showed significantly higher 
percentage of Cortisol hypersecretion and all non-suppressors were hypersecretory. 
The function of adrenal cortex in de-
pression is the most thoroughly studied 
aspect of clinical psychoendocrinology. 
Disturbance in the activity of Hypothala-
niopituitary Adrenal (HPA) axis has been 
the subject ot extensive research. The im-
portance ot the study of the UFA axis is due 
to the supposed relationship between life 
stress and depression and the clinical asso-
ciation between depression and diseases of 
the Pituitary - Adrenal system. It is now 
well accepted that in patients with depres-
sion the baseline plasma Cortisol level is ele-
vated and also there is disturbance in the ci-
rcadian rhythms of Cortisol secretion (Car-
roll et al 1976, Schelesser et al 1980). The 
abnormal escape from suppression with de-
xamethasone has been an area of particular 
interest. Carroll et al (1981) standardised 
the procedure for dexamethasone suppres-
sion test (DST). In their study DST identi-
fied patients with melancholia, a subtype of 
major depressive disorder (MDD) defined 
in DSM III (APA 1980), with a sensitivity 
of 67% and a specificity of 96%. Non-su-
pression was found to be a marker of the 
state of melancholia and was not influenced 
by other factors such as age, sex, frequency 
of episodes, duration of illness, severity of 
depression or psychotropic drugs, provided 
factors which can produce false negative 
and false positive results are eliminated. 
The diagnostic usefulness of DST in de-
pression has been supported by the reports 
of Targum ct al (1982) Mcndlewicz et al 
(1982) Evans et al (1983) and Schat/bcrgct 
al (1983). Hut several others workers Spar 
et al (1982), Coppcn ct al (1983), I lallstrom 
ct al (1983) and Bcrger et al (1984) ques-
tioned the diagnostic validity of DST by 
discussing several methodological prob-
lems in the earlier studies. 
The present work is designed to study 
the HPA axis dysfunction, by measuring 
the baseline plasma Cortisol levels and stu-
dying the response to dexamethasone, in 
patients with MDD. The procedure was 
based on the procedure described by Car-
roll et al (1981). 
Material and Methods 
25 patients (15 males and 10 females) 
who fulfilled the criteria in DSM III (APA 
1980) for MDD were included in the expe-
rimental group. The control group consist-
ed of 25 patients (14 males and 11 females) 
with psychiatric diagnosis other than MDD 
based on DSM III criteria. 
Exclusion Criteria: 
Organic brain syndromes and any major 
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physical illness 
Endocrine disorders, pregnancy 
Severe weights loss and malnutrition 
Ongoing treatment with steriods, barbi-
turates, phenytoin, meprobamate, reser-
pine, high dose of benzodiazepine 
(more than 25 nigs/day). 
Spironolactone and cyproheptadine. 
These patients were excluded because 
they have been known to give either false 
positive or false negative results in DST. 
All the patients were evaluated in detail 
and data was collected regarding the age, 
sex, occupation, marital status, socioeco-
nomic status, age of onset of the first epi-
sode, previous episodes and frequency, fam-
ily history of psychotropic drug intake and 
presence of features of melancholia accord-
ing to DSM III criteria. The severity of de-
pression was rated on Hamilton's ratings 
scale for depression. No restriction was im-
posed on the diet and activity of patients. 
The test procedure was explained to the pa-
tients and their relatives and their consent 
was obtained. 
After taking the blood sample at 11 p.m. 
on the first day, patient was given 1 mg. of 
dexamethasone orally. Further blood 
samples were collected at 4 p.m. and 11 
p.m. on the second day. From the hepari-
nised blood sample, plasma was separated 
and stored at - 20° C and Cortisol level esti-
mated in batches. Estimation of plasma Cor-
tisol was done by radio-immunoassay tech-
nique. The assay was done using RIA kit 
supplied by Biodata Company, Italy. The 
estimation was done using Packard 5650 
Automatic gamma counter. The psychiatr-
ist who evaluated the patient was blind to 
the Cortisol levels and the biochemist was 
not aware of the clinical diagnosis till the 
entire data was collected. The value taken 
for non-suppression was plasma Cortisol le-
vel of £ 5 Mcg/dl. 
Results 
Analysis of demographic data showed 
no significant difference between the two 
groups regarding sex distribution, marital 
status and socioeconomic status. There was 
statistically significant difference in the 
mean age between the experimental and 
control groups (Mean Age in MDD Croup 
40.59 ± 13,54; Control Group 25.64 ± 
9.52; V < 0.001). 
There was no significant difference in 
non-suppression when MD1) group as a 
whole was compared with the control 
group. But within the MDD group, only 
patients with melancholia showed non-
suppression and this was statistically signi-
ficant in comparison with MDD without 
melancholia. The sensitivity of DST for 
diagnosis of melancholia in comparison 
with the control group was 46.15% and 
specificity was 96%. Non-suppression did 
not have any correlation with other factors 
like past history of affective illness, dura-
tion of present episode and unipolar or 
bioplar nature of the illness (Table 1 & 2). 
Non suppression was also not influenced 
by the severity of depression as measured on 
Hamilton's Rating Scale for depression. Even-
though there was statistically significant dif-
ference in mean age between the experimen-
tal and control groups, there was no differ-
ence between suppressors and non-suppres-
sors in the age distribution (Table 3). 
Non suppression was observed in all the 
age groups (one patient in 21-30 years 
group; two patients in 31 to 40 years group; 
two patients in 51 to 60 years group and one 
in 61 to 70 years group) thereby showing that 
age was not the influencing factor. 
There was no statistically significant dif-
ference between the MDD and control 
groups regarding pre-dexamethasone Cortisol 
level. But within the group of MDD signifi-
cantly higher percentage of patients with me-
lancholia were hypcrsecrctors (Table 4). M. SAIKUMAU It EDDY AND K. KUKUVILLA  197 
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Table 2 
Non-supression in the Groups 
Suhiect 
Group 
MOD Croup 
Control Group 
Melancholies 
Non-melancholies 
Unipolar 
Bipolar 
Past History of Affective 
Present 
Absent 
Duration of Illness 
< 6 months 
> ti months 
No. 
25 
25 
13 
12 
21 
4 
Illness 
10 
15 
18 
7 
No 
su 
i. ot Non-
ppressors 
6 
1 
6 
0 
5 
t 
2 
4 
4 
2 
Percentage  of 
Non-suppressors 
24 
4. 
46.15 
0 
23.8 
25 
10 
26.66 
22.22 
28.5 
Statistical 
Significance 
NS 
H < .01 
NS 
NS 
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Tabic 3 
Demographic Data «i HDS Score 
Sex .Marital Status Socioeconomic Status 
Subject Group No. M F M S D/W L M U \fc Hl>S Score 
Noli Suppressors 6 4 2 4 1 1 - 2 3 1 45.5 36.8 
Suppressor. 7 4 3 5 11 3 J 1 47 33.3 
Statist" al 
Siitmfuan.e NS NS NS NS NS 
Table 4 
Ilyperjecretori in the Groups 
(Based on Pre-Dexamethasone 4 P.M. Cortisol Levels) 
Subject Group No Hy persecutors Significance 
MOD Croup 25 14 
Control Group 25 8 NS 
MDD with Melancholia 13 11 
MUD without Melancholia 12 1 P < .001 
Non-suppretiori 6 6 
Suppressors 7 5 NS 
Criterion for Hypersecretion - Baseline Plasma Cortisol Value of ;> 5/Vg/Jl 
Discussion 
Results of the present study indicate 
that non-suppression to DST is a state mar-
ker of melancholia and is not influenced by 
any of the demographic factors and other 
clinical variables. This finding is in agree-
ment with the reports of other workers 
(Carroll et al 1981, Mcndlewiez ct al 1982, 
Schatzberg ct al 1983, Targum ct al 1982). 
Eventhough there is some agreement 
regarding the diagnostic usefulness of DST 
in melancholia, the predictive value of the 
test varied in different studies. The variabil-
ity has been attributed to diagnostic criteria 
used for sample selection, dose of dexame-
thasone administered, timing of the sample, 
method of estimation of plasma Cortisol and 
the criterion value taken for non-suppres-
sion. The influence of different methods of 
estimation on the results has been discussed 
by Maruta (1982), Fang (1982) and Meltzer 
and Fang (1983). 
Strokes et al (1984) argued that age and 
gender may affect the result and Berger et 
at (1984) discussed that stress of hospital ad-
mission and psychotropic drugs are some of 
the factors influencing non-suppression. 
The results of present study do not sup-
port the above possibility. Non-suppression 
was found both in outpatients and inpa-
tients and also in patients on psychotropic 
drugs and those without. 
It is widely discussed that weightloss is a 
significant factor influencing non-suppres-
sion. But Coppcn et al (1984) in their study 
of two groups - Depression with weight 
loss and depression without weight loss 
does not necessarily result in an abnor-
mal DST result. They have shown non-sup-
pression was seen in 73 % of depressive with M. SAIKUMAR REDDY AND K. KURUVILLA  1V9 
weigh tloss and in 61 % of depressive wi-
thout weight loss. 
Carroll et al (1981) suggested that two 
samples taken at 4 p. m and 11 p. m. increase 
the sensitivity of the test. In our study the 4 
p. m. sample alone identified all the positive 
results. This indicates that DST can lie done 
with the 4 p. m. sample alone without loss 
of sensitivity or specificity. The importance 
oi this finding is regardingthe cost of the 
procedure and also in administration for 
outpatients. 
In conclusion the results of our study 
show that DST is a laboratory test useful for 
the diagnosis of melancholia. Hut the re-
sults should be interpreted with caution 
considering the small sample size. Further 
research along with the other tests ot neu-
roendocrine battery may prove useful in 
identification of specific diagnostic tests for 
depressive illness. 
It may be interesting to see the treat-
ment responses in relation to DST and 
Brown et al (1980) have reported better re-
sponse in a significantly higher percentage 
ot non-suppressors compared to suppres-
sors. A project regarding treatment re-
sponse is under current investigation by the 
authors. 
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